Histology and Cytology Market Revenue Analysis & Region and Country Forecast To 2027

Comments · 554 Views

global histology and cytology market was valued at USD 12.61 Billion in 2019 and is expected to reach USD 34.51 Billion by the year 2027

 

 

Rising prevalence of cancer, growing standardization of pathological laboratories, technological advancements in diagnostic and molecular techniques for histology and cytology procedures, and favorable reimbursements for cancer screening and laboratory tests are major factors contributing to high CAGR of Histology and Cytology market during the forecast period.

According to the recent analysis of Reports and Data, the global histology and cytology market was valued at USD 12.61 Billion in 2019 and is expected to reach USD 34.51 Billion by the year 2027, exhibiting a CAGR of 13.2%. Histology and Cytology procedures are related to the diagnosis of diseases and other conditions. Histology is the study of human tissues, which includes structure and function, whereas cytology is the study of human cells. Histology and cytology market had experienced a huge growth with regards to healthcare industries as several fatal diseases can be diagnosed through these clinical studies.

Get a sample copy of the global Histology and Cytology market report @ https://www.reportsanddata.com/sample-enquiry-form/2194

The global pharma healthcare market revenue growth is majorly driven by factors such as rising prevalence of chronic and acute diseases globally, rise in global geriatric population, growing awareness of health wellness among consumers, and growing demand for advanced medications and therapeutics. Growing need for advanced, patient-centered healthcare services, increasing availability of advanced point-of-care diagnostics, increasing biotechnological and pharmaceutical research development activities and clinical trials, and rise in public and private investments in the healthcare industry are some of the other major factors supporting market revenue growth. Market revenue growth is further driven by factors such as rising cases of the novel coronavirus disease, rising focus on development of rapid COVID-19 diagnostics including the RT-PCR test kits, increasing government intiatives towards manufacturing and distribution of COVID-19 vaccines, rising trends of telehealth and telemedicine, and growing need for remote patient care monitoring solutions.

Leading Players in the Global Pharma Healthcare Market:

Abbott Laboratories; Becton Dickinson and Company; BrandTech Scientific, Hoffmann-La Roche Ltd.; Hologic, Inc.; Life Technologies Corporation; Sysmex Corporation; Thermo Fisher Scientific, Inc.; Southwest Precision Instruments, and Trivitron Healthcare

Regional Outlook of the Global Histology and Cytology Market:

Under this section of the report, the authors comprehensively analyze the key regional markets in the global Histology and Cytology market. This section accurately evaluates the revenue shares and year-on-year revenue growth rate of these regional markets. Key regional markets encompassed in the report include North America, Europe, Asia Pacific, Latin America, and the Middle East Africa.

 

Avail a Order on the report @ https://www.reportsanddata.com/report-pricing/2194

Detailed Regional Market Segmentation

  • North America
    • S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • K.
    • Italy
    • France
    • BENELUX
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Rest of LATAM
  • Middle East Africa
    • Saudi Arabia
    • A.E.
    • South Africa
    • Rest of MEA

Further key findings from the report suggest

  • Histology and cytology market had experienced a huge growth in the healthcare industry as several fatal diseases can be diagnosed through these clinical studies
  • Roche launched the VENTANA DP 200 slide scanner which is a high-speed slide scanner for digital pathology in March 2019. It reduces workflow errors and improves image quality. Such product launches are expected to drive histology and cytology market
  • Cytology testing attributed to large disease prevalence and adoption of the test for cervix screening. The segment can maintain its leading position during the forecast period due to the recent entry of various tests and advantages over histology such as faster analysis and cost-effectiveness
  • Flow Cytometry sub-segment was expected to show the maximum CAGR during the forecast period within the test type segmentation of the histology and cytology. This segment is used to detect and measure characteristics of cell mainly used in laboratories which contribute to the market growth of this product segment
  • The histology and cytology market will prove advantageous to the Asia-Pacific region to a great extent. It’s CAGR was the highest amongst all regions during the forecast period.The major factor driving the growth of this market is the huge population density in countries like India and China and increasing awareness about these tests
  • In September 2019, Phillips launched computational pathology software, Tissue Mark, for automated ovarian and prostate tumor detection, which provides doctors and lab technicians with an effective histology and cytology diagnosis tool

Request a customized copy of the Histology and Cytology market report @ https://www.reportsanddata.com/request-customization-form/2194

Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.

 Explore More Industry Research by Reports and Data:

Colonoscopy Bowel Preparation Drugs Market @ https://www.biospace.com/article/colonoscopy-bowel-preparation-drugs-market-analysis-statistics-revenue-demand-and-trend-analysis-research-report-by-2028/

Anti-Inflammatory Antibiotics Eyedrops Market @ https://www.biospace.com/article/anti-inflammatory-antibiotics-eyedrops-market-competitive-landscape-research-methodology-business-opportunities-statistics-and-industry-analysis-report-by-2027/

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

 

 

 

 

 

 

 

Comments